Calendar Moberg Pharma AB

Equities

Market Closed - Nasdaq Stockholm Other stock markets 04:29:37 30/04/2024 pm IST			5-day change	1st Jan Change
34.14 ^SEK	+0.41%		+14.10%	+124.61%

08/04	Moberg Pharma AB Submits Application to Include an Additional Terbinafine Supplier	CI
26/02	Certain Ordinary Shares of Moberg Pharma AB are subject to a Lock-Up Agreement Ending on 26-FEB-2024.	CI

9.IHME1vr3YF4wJFf-2cn_u0IW9E4mjEn4fCfSYeOmKDY.VzwysK-0BhpbQyHGvb6a4wFmzXxk0zC1S3GnJaefHnh0FzyujJgKMAZGZw~e4caa61873feba1f47c150a50dc85a1d

07/05/2024 11:30 am	Q1 2024 Earnings Release
14/05/2024 05:30 pm	Annual General Meeting
13/08/2024 11:30 am	Q2 2024 Earnings Release
12/11/2024 12:30 pm	Q3 2024 Earnings Release
11/02/2025	Q4 2024 Earnings Release (Projected)
13/05/2025	Q1 2025 Earnings Release (Projected)
12/08/2025	Q2 2025 Earnings Release (Projected)
11/11/2025	Q3 2025 Earnings Release (Projected)

13/02/2024 12:30 pm	Q4 2023 Earnings Release
13/02/2024	Q4 2023 Earnings Call
23/11/2023 03:50 pm	Redeye Life Science Day
07/11/2023 12:30 pm	Q3 2023 Earnings Release
07/11/2023	Q3 2023 Earnings Call
06/11/2023	Bio-Europe Conference
11/10/2023	European Academy of Dermatology and Venereology Conference
09/10/2023 01:00 pm	Extraordinary Shareholders Meeting
31/08/2023	Redeye Investor Forum
11/08/2023	Rights Issue: 16 new shares @ 5.75 SEK for 9 existing shares
11/08/2023	Rights Issue: 16 new shares @ 5.75 SEK for 9 existing shares
08/08/2023 05:30 pm	Extraordinary Shareholders Meeting
03/08/2023 11:30 am	Q2 2023 Earnings Release
03/08/2023	Q2 2023 Earnings Call
01/06/2023	Redeye Growth Day
24/05/2023	Reverse Split: 1 of 10
16/05/2023 08:00 pm	Annual General Meeting
10/05/2023	Redeye Investor Forum
09/05/2023 11:30 am	Q1 2023 Earnings Release
30/03/2023	Swiss Nordic Bio Conference

04/02/2021

0 SEK

Fiscal Period	December	2019	2020	2022	2023
Net sales Million SEK	Released Forecast Spread	15,6 0,00 -	50,5 0,00 -	0,21 21,0 -99.01%	0,00
EBITDA Million SEK	Released Forecast Spread	-3,00 -20,0 85%	29,0 14,5 100.35%	-17,6 -17,0 -3.79%	-25,4
EBIT Million SEK	Released Forecast Spread	-4,22 -20,0 78.9%	26,4 13,2 99.82%	-20,2 -21,0 3.69%	-27,5
Earnings before Tax (EBT) Million SEK	Released Forecast Spread	-5,07 -21,0 75.88%	25,4 12,0 111.91%	0,00 0,00 -	-25,4
Net income Million SEK	Released Forecast Spread	559 -21,0 2761.02%	20,0 9,51 110.49%	-15,7 0,00 -	-21,1
EPS SEK	Released Forecast Spread	314 -12,0 2712.5%	10,6 5,02 111.27%	-2,10 0,00 -	-1,33
Announcement Date		27/09/19	11/08/20	07/02/23	13/02/24

Today 11:00 am	NOVO NORDISK A/S: Q1 2024 Earnings Release
Today 05:00 pm	ORGANON & CO.: Q1 2024 Earnings Release
03/05/2024	SCINOPHARM TAIWAN, LTD.: Q1 2024 Earnings Release (Projected)
03/05/2024	AARTI DRUGS LIMITED: Q4 2024 Earnings Release
03/05/2024	ALK-ABELLÓ A/S: Q1 2024 Earnings Release
03/05/2024	DEVA HOLDING: Q1 2024 Earnings Release (Projected)
03/05/2024 03:30 pm	AMNEAL PHARMACEUTICALS, INC.: Q1 2024 Earnings Release
06/05/2024	GEN ILAC VE SAGLIK URUNLERI SANAYI VE TICARET ANONIM SIRKETI: Q1 2024 Earnings Release (Projected)
06/05/2024	PLIANT THERAPEUTICS, INC.: Q1 2024 Earnings Release (Projected)
06/05/2024	AVADEL PHARMACEUTICALS PLC: Q1 2024 Earnings Release (Projected)

Today	BAUSCH HEALTH COMPANIES INC.: Q1 2024 Earnings Release
Today	AMGEN INC.: Q1 2024 Earnings Release
02/05/2024 01:35 am	CORCEPT THERAPEUTICS INCORPORATED: Q1 2024 Earnings Release
02/05/2024 01:35 am	JAZZ PHARMACEUTICALS PLC: Q1 2024 Earnings Release
01/05/2024 04:15 pm	PFIZER, INC.: Q1 2024 Earnings Release
01/05/2024 12:30 pm	HALEON PLC: Q1 2024 Sales and Revenue Release - Trading Statement
01/05/2024 11:30 am	GSK PLC: Q1 2024 Earnings Release
01/05/2024	INNOVIVA, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024	PACIRA BIOSCIENCES, INC.: Q1 2024 Earnings Release (Projected)
01/05/2024	EYEPOINT PHARMACEUTICALS, INC.: Q1 2024 Earnings Release (Projected)